Fact checked byGina Brockenbrough, MA

Read more

June 16, 2024
1 min read
Save

Canary Medical receives FDA breakthrough device designation for smart lumbar cartridge

Fact checked byGina Brockenbrough, MA
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Key takeaways:

  • Canary Medical received breakthrough device designation of its Canturio lumbar cartridge.
  • The application features a smart sensor that displays kinematic data of patients undergoing spine surgery.

Canary Medical announced it received FDA breakthrough device designation of its Canturio lumbar spine cartridge for use with its implanted reporting processor system, according to a press release.

The Canturio lumbar cartridge is a smart sensor application that allows surgeons to view kinematic data to assess treatment and risk of degenerative disc disease, instability and non-fusion in patients who undergo spine procedures. The application is designed for use with a lumbar interbody system.

Generic FDA News infographic
Canary Medical received breakthrough device designation of its Canturio lumbar cartridge.

“The approval of [Canturio lumbar cartridge] is the fourth time in-a-row that a Canary Medical product has received breakthrough device designation from the FDA, an unparalleled accomplishment in our industry,” Bill Hunter, MD, founding member and CEO of Canary Medical, said in the release.